The Indiana Senate voted unanimously last week to require the Indiana Medicaid program to pay home health agencies, rural health clinics and federally qualified health centers for doing medical consultations, diagnoses and monitoring using videoconferencing, telephones or computers.
Eli Lilly and Co. has sued Roche Holding AG’s Genentech unit, asking a court to invalidate patents used to make treatments for cancer and autoimmune diseases.
The sequestration plan kicking in Friday will chop Medicare payments to hospitals, doctors and nursing homes by 2 percent, beginning April 1. One study estimates that the cuts could result in 10,000-plus job losses in Indiana alone.
The five-year trend of physician practices marrying up with hospitals has made it harder and harder for independent physician practices to spend time in more than one hospital system.
The Indiana Senate voted Tuesday to expand Medicaid using a state-run program, as lawmakers and Gov. Mike Pence continue negotiating how the state should cover an estimated 400,000 low-income residents.
Endocyte Inc. saw its shares fall nearly 7 percent Tuesday morning after the drug development firm announced that its application for U.S. approval of a cancer drug could be delayed another 10 months.
What are Zeke Turner's top five strategies for keeping his work week under 40 hours? Do you really need work e-mail on your smart phone? What's it like to take a company public? The real estate exec has answers.
The actuarial firm hired by the state estimates savings of about $156 million per year if Indiana uses its Healthy Indiana Plan to expand Medicaid coverage.
Between the new Marian college of medicine and an enrollment expansion at the Indiana University School of Medicine, the state will have 88 percent more med students by next fall.
Researchers suspect the sex hormone known to increase libido and musculature could also play a role in preventing a form of diabetes that tends to strike later in life and afflicts more than 330 million people worldwide.
The cost of health care for an additional 400,000 low income residents is something nobody in the Indiana Statehouse seems to be able to agree upon this year, even as the crucial decision about whether to expand Medicaid bears down on lawmakers midway through their annual session.
Indianapolis-based Dow Agrosciences LLC and two other pesticide makers won a bid to overturn U.S. National Marine Fisheries Service proposals to protect salmon when an appeals court found the agency’s decision “arbitrary and capricious.”
It's way too early to declare the board dysfunctional for making a surprise choice—Joe Swedish, CEO of Michigan-based hospital system Trinity Health—for the company’s new CEO.
Decisions by other Republican governors to support Medicaid expansion is increasing pressure on Indiana’s governor to do the same.
Gov. Mike Pence is battling with House lawmakers over expanding health care coverage for roughly 400,000 Indiana residents, amid concerns that the state's health care program for the poor won't be able to handle the flood of new enrollees.
The Indianapolis-based health insurer expects to return about $2 billion to shareholders this year, through the dividend and share buybacks.
Roche AG and Eli Lilly and Co., two drugmakers racing to develop treatments for some of the least understood brain disorders, may gain the most from a U.S. government boost in funding to fully map the human brain.
The new partnership between Community Health Network and Wishard Health Services could put a third health care entity in an awkward position: the Indiana University School of Medicine. Virtually all of the nearly 1,100 physicians who practice at Wishard Memorial Hospital and its community clinics come from the IU medical school.
Half of the candidates to replace retiring dean Dr. Craig Brater are from the IU medical school and the other half are outsiders, according to a release issued Monday by the Indiana University School of Medicine.
Community Health Network’s new partnership with Wishard Health Services will create a primary-care behemoth that the systems argue will put them in the best position possible to handle the changes coming from federal health reform.
